3PC-055 Cytotoxic agents: skin tests for the diagnosis of drug hypersensitivity. (March 2019)

• Record Type: Journal Article
• Authors: Legendre, P; Bonnaure, AC; Bellay, R; Lester, MA; Boivin, PN
• Is Part Of: European journal of hospital pharmacy. Volume 26(2019)Supplement 1
• Page Start: A61
• Page End: A62
• Publication Date: 2019-03
• Subjects: Pharmacy -- Periodicals; Hospital pharmacies -- Periodicals; 615.1
• DOI: 10.1136/ejhpharm-2019-eahpconf.136
• Languages: English
• ISSNs: 2047-9956

Abstract

Abstract : Background: Skin tests have an important place in the diagnosis of hypersensitivity. Because of a lack of precise skin tests procedures, drug skin tests are often not carried out. However, they could help to determine the cause of hypersensitivity and help in the choice of therapeutic strategy. In our hospital, a dermatologist required us to produce skin tests with cytotoxic and anti-HER2 antibody agents (docetaxel, pertuzumab, trastuzumab) in order to evaluate the hypersensitivity of a patient who developed a photosensitive dermatosis after a second cycle of chemotherapy. Purpose: The aim of this project was to produce a feasibility study for the production of skin tests with these three molecules. Material and methods: A literature review was performed to find data about skin tests, and more particularly about safety and non-irritant drug concentrations. Because of a lack of data, we also decided to realise an investigation near the others hospital centres. Chemical tests were carried out such as the measure of the drug pH and the miscibility between the diluant and the medicine. Results: According to the literature, the pH drug must be between 6 and 9 to avoid skin injuries. By its acidic pH, docetaxel could not be used to produce a patch test (non-diluated drug pH=3, diluated with 0.9 per cent sodium chloride drug pH=4). The pH of the two other agents and of the diluant was acceptable (pH=7). In most of the publications, the excipient used for the preparation of patch tests was petroleum jelly. In cooperation with the doctor, we decided to produce a prick test with docetaxel, prepared by diluting the drug to 5 mg/ml in an aqueous solution of 0.9% sodium chloride. Concerning pertuzumab and trastuzumab, patch tests were obtained by realizing an homogeneous preparation, with a concentration of 30% in petrolatum. Conclusion: The literature deals mainly with a platinum agent, and more often with skin prick tests and intradermal tests. We were confronted with the difficulty of possessing poor data when facing the request of the dermatologist. Moreover, according to the literature, patch tests commonly reveal false negative results. This activity necessitates the development of a local thesaurus and an economic study. References and/or acknowledgements: No conflict of interest.